Hearing:
Investing in the U.S. Health System by Lowering Drug Prices, Reducing Out-of-Pocket Costs, and Improving Medicare Benefits
Committee on Ways and Means
Thursday, October 17, 2019 (10:00 AM)
1100 LHOB
Washington, D.C.
Witnesses
Samantha Reid
Patient, Crohn's Disease
Added
10/17/2019 at 10:28 AM
- Witness Statement
[PDF]
Added
10/17/2019 at 10:33 AM
- Witness Truth in Testimony
[PDF]
Added
10/17/2019 at 10:39 AM
Catherine Alicia Georges EdD, RN, FAAN
National Volunteer President, AARP
Added
10/17/2019 at 10:28 AM
- Witness Statement
[PDF]
Added
10/17/2019 at 10:33 AM
- Witness Truth in Testimony
[PDF]
Added
10/17/2019 at 10:39 AM
Mark E. Miller PhD
Executive Vice President of Health Care, Arnold Ventures
Added
10/17/2019 at 10:28 AM
- Witness Statement
[PDF]
Added
10/17/2019 at 10:33 AM
- Witness Truth in Testimony
[PDF]
Added
10/17/2019 at 10:39 AM
Judy Feder PhD
Professor and Dean, Georgetown Georgetown University McCourt School of Public Policy
Added
10/17/2019 at 10:28 AM
- Witness Statement
[PDF]
Added
10/17/2019 at 10:33 AM
- Witness Truth in Testimony
[PDF]
Added
10/17/2019 at 10:39 AM
Benedic N. Ippolitio PhD
Research Fellow, American Enterprise Institute
Added
10/17/2019 at 10:28 AM
- Witness Statement
[PDF]
Added
10/17/2019 at 10:33 AM
- Witness Truth in Testimony
[PDF]
Added
10/17/2019 at 10:39 AM
First Published:
October 15, 2019 at 09:52 AM
Last Updated:
October 17, 2019 at 10:42 AM